The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Spinogenix will be collaborating with Dr. Rita Sattler and Dr. Justin Ichida on a grant awarded from the DOD's CDMRP to evaluate its lead development ...
read more
MEI Pharma announced that the Phase 1b trial arm exploring zandelisib, in combination with zanubrutinib, completed the safety evaluation stage in ...
read more
Thursday, January 07, 2021
Anixa Biosciences announced the FDA has cleared the IND application for its breast cancer vaccine.
read more
Wednesday, January 06, 2021
CNS announced the IND application for its lead product candidate, Berubicin, for the treatment of GBM is now approved and in effect as filed with the ...
read more
Wednesday, January 06, 2021
OSE has obtained funding under the PSPC-COVID call for projects to support its development program on CoVepiT, its second-generation multi-target ...
read more
Tuesday, January 05, 2021
Provention Bio announced the initiation of PROVENT, a first-in-human study of its polyvalent inactivated coxsackievirus B vaccine candidate, PRV-101.
read more
Tuesday, January 05, 2021
Grünenthal announced the first participants have been enrolled in a Phase I trial of a peripherally restricted Nociceptin/orphanin peptide receptor ...
read more
Tuesday, January 05, 2021
Creative Medical Technology Holdings announced positive preclinical data supporting the utilization of its ImmCelz cell-based immunotherapy for ...
read more
Dynavax announced the CHMP has issued a positive opinion on the company's Marketing Authorization Application, recommending the granting of marketing ...
read more
V2ACT Therapeutics has obtained permission from the FDA on an IND application and may proceed with the clinical investigation of V2ACT in trial for ...
read more
The EspeRare Foundation and the Pierre Fabre group have entered into a license and development collaboration agreement for the development and ...
read more
Thursday, December 31, 2020
AstraZeneca Pharmaceuticals
AstraZeneca’s COVID-19 vaccine has been approved for emergency supply in the UK.
read more
Wednesday, December 30, 2020
HemoShear has achieved a research milestone in its discovery and development collaboration with Takeda Pharmaceutical to advance its first NASH target...
read more
Tuesday, December 29, 2020
Merck has entered into an agreement with the United States Government to support the development, manufacture and initial distribution of an ...
read more
Tuesday, December 29, 2020
Neurana announced positive top-line results from the Phase 1 CNS clinical study of tolperisone.
read more